Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK: Commercial Framework Sheds Light On Working With NHS And NICE

Executive Summary

The final text brings some changes, including the introduction of an escalation process when companies and NHS England cannot agree.

You may also be interested in...



Fair Pricing A Key Feature Of NHS England Drug Funding Proposals

Plans for a new commercial framework for publicly funded medicines in England are out for consultation. The concept of fair and responsible pricing figures large in the proposals.

Regulators Call for More Harmonization On Ultra-Rare ATMPs

Early discussions between companies and multiple regulators could drive greater alignment among jurisdictions.

Can The UK Remain A First Launch Market?

More pollical support from the National Health Service and health ministers is needed to ensure the UK’s future as a desirable launch market.

Topics

UsernamePublicRestriction

Register

PS143850

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel